Reply: Revisiting the use of albumin in patients with cirrhosis - trial design matters [0.03%]
评论：重新考虑在肝硬化患者中使用白蛋白的意义——试验设计很重要
Marten A Lantinga,Elliot B Tapper,Joost P H Drenth
Marten A Lantinga
Xi Zhou,Zhibo Ma,Qi Cheng et al.
Xi Zhou et al.
Background: Liver injury, a common pathophysiological basis of various liver diseases, is associated with inflammation. Hepatic nerves regulate inflammation. However, the specific signals that trigger inflammation and met...
Clinical and Pathophysiological Characteristics of Non-acute Decompensation of Cirrhosis [0.03%]
非急性失代偿性肝硬化的临床和病理生理特征
Nipun Verma,Parminder Kaur,Pratibha Garg et al.
Nipun Verma et al.
Background & aims: The heterogenous presentation patterns in decompensated cirrhosis confers variable outcomes. While acute decompensation (AD) is well-characterised with poorest prognosis, presentation as non-acute decom...
Géraldine Dahlqvist,Pierre Deprez,Nicolas Lanthier
Géraldine Dahlqvist
Letter to the editor: Several questions about the study of hypothermic oxygenated machine perfusion [0.03%]
致编辑的一封信：关于低温氧气机器灌注研究的几个问题
Hanwen Yang,Simeng Lei,Zhili Ji
Hanwen Yang
Recompensation of decompensated cirrhosis in hepatitis C patients after SVR: Prognostic implications [0.03%]
丙型肝炎患者在获得持续病毒学应答后失代偿期肝硬化的再代偿：预后的意义
Yolanda Sánchez-Torrijos,Paula Fernández-Álvarez,Jose Miguel Rosales et al.
Yolanda Sánchez-Torrijos et al.
Backgound&aims: The Baveno VII consensus introduced the term "recompensated cirrhosis," though few studies have examined its clinical relevance. We analyzed the rate and predictors of recompensation in hepatitis C (HCV) p...
Hot and Cold Fibrosis: The Role of Serum Biomarkers to assess the Immune Mechanisms and ECM-Cell Interactions in Human Fibrosis [0.03%]
热与冷的纤维化：血清生物标志物在人类纤维化免疫机制和ECM-细胞相互作用评估中的作用
A Zawadzki,D J Leeming,A J Sanyal et al.
A Zawadzki et al.
Fibrosis is a pathological condition characterized by excessive accumulation of extracellular matrix (ECM) components, particularly collagens, leading to tissue scarring and organ dysfunction. In fibrosis, an imbalance between collagen synt...
Reply to "Pharmacological inhibition of ATGL as therapeutic approach for MASH: Far beyond the lipase suppression role of ATGL inhibitors" [0.03%]
对“药理学抑制ATGL作为治疗MASH的方法：远超ATGL抑制剂的脂酶抑制作用”作出回应
Emmanuel Dauda Dixon,Thierry Claudel,Michael Trauner
Emmanuel Dauda Dixon
Reply to : "Long-term outcome following liver transplantation of patients with ACLF grade 3 : Need of redefining boundaries ?" [0.03%]
对《肝脏移植在ACLF 3级患者中长期预后的探讨：重新定义边界的必要性？》一文的回复
Florent Artru,Jose Ursic-Bedoya,Sebastien L&#x;Hermite et al.
Florent Artru et al.
Circadian Control of Hepatic Ischemia/Reperfusion Injury via HSD17B13-Mediated Autophagy in Hepatocytes [0.03%]
通过肝细胞中HSD17B13介导的自噬实现肝脏缺血/再灌注损伤的昼夜节律控制
Hui Wang,Meina Guo,Baoyin Ren et al.
Hui Wang et al.
Background & aims: Studies have illustrated the role of circadian rhythm in hepatic ischemia/reperfusion injury (HIRI), but the mechanisms are poorly understood. Bmal1 is the most important gene that plays significant rol...